How to manage patients with corticosteroids in oncology in the era of immunotherapy?-Reference-Cited by-同舟云学术

How to manage patients with corticosteroids in oncology in the era of immunotherapy?

Published:2020-12 Issue: Volume:141 Page:239-251
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Aldea Mihaela^ORCID,Orillard Emeline^ORCID,Mansi Laura,Marabelle Aurélien,Scotte Florian,Lambotte Olivier,Michot Jean-Marie^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference88 articles.

1. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs;Rhen;N Engl J Med,2005

2. The effects of the adrenal cortical hormone 17-hydroxy-11-dehydrocorticosterone (Compound E) on the acute phase of rheumatic fever; preliminary report;Hench;Proc Staff Meet Mayo Clin,1949

3. Corticosteroids: clinical pharmacology and therapeutic use;Swartz;Drugs,1978

5. The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study;Michot;Eur J Canc,2020

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A tumor-responsive nanostrategy for reducing the risk of immunotherapy-related myocarditis;Chemical Engineering Journal;2024-08

2. Treatment Options for Brain Metastases;Current Treatment Options in Oncology;2024-07-22

3. Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review;European Journal of Cancer;2024-07

4. Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments;International Journal of Pharmaceutics;2024-07

5. Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment—The Experience of Ion Chiricuță Oncology Institute;Cancers;2024-05-26